Back
FTI Consulting Vs. Denali Therapeutics Industry Stock Comparison
Buy
57
FCN
FTI Consulting
Last Price:
222.64
Seasonality Move:
7.3%
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.74
Seasonality Move:
17.79%
Buy
57
FTI Consulting (FCN)
is a Buy
Is FTI Consulting a Buy, Sell or Hold?
- The current FTI Consulting [FCN] share price is $224.12. The Score for FCN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- FCN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.68. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FCN Stock Price Chart
What is FTI Consulting's stock price today?
-
The FTI Consulting share price today is $224.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCN is experiencing slight buying pressure.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.
FCN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 55.46 | Buy |
Chaikin Money Flow: | 6509 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (219.98 - 224.86) | Buy |
Bollinger Bands (100): | (213.77 - 224.47) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.67 | Buy |
Relative Strength Index (14 RSI): | 77.92 | Buy |
Chaikin Money Flow: | 34344 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.24 - 27.72) | Buy |
Bollinger Bands (100): | (18.96 - 25.08) | Buy |
FCN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 220.54 | Buy |
20-day SMA: | 222.48 | Buy |
50-day SMA: | 222.23 | Buy |
200-day SMA: | 211.76 | Buy |
8-day EMA: | 222.04 | Buy |
20-day EMA: | 221.9 | Buy |
50-day EMA: | 220.97 | Buy |
200-day EMA: | 212.22 | Buy |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28 | Buy |
20-day SMA: | 26.04 | Buy |
50-day SMA: | 24.18 | Buy |
200-day SMA: | 20.53 | Buy |
8-day EMA: | 28.54 | Buy |
20-day EMA: | 26.57 | Buy |
50-day EMA: | 24.56 | Buy |
200-day EMA: | 22.12 | Buy |
FTI Consulting Earnings Growth & FCN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.55 per share, an increase this year of $1.43 per share, and an increase next year of $0.91 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
FTI Consulting Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |